日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhancing RNA base editing on mammalian transcripts with small nuclear RNAs

利用小核RNA增强哺乳动物转录本的RNA碱基编辑

Smargon, Aaron A; Pant, Deepak; Gomberg, Trent A; Fagre, Christian; Glynne, Sofia; Nguyen, Johnathan; Naritomi, Jack T; Gilbert, Wendy V; Yeo, Gene W

Dual-targeting snRNA gene therapy rescues STMN2 and UNC13A splicing in TDP-43 proteinopathies

双靶向snRNA基因疗法可挽救TDP-43蛋白病中的STMN2和UNC13A剪接

Gomberg, Trent A; Elmsaouri, Sara; Kopalle, Hema M; Baughn, Michael W; Beccari, Melinda S; McAlonis-Downes, Melissa; Artates, Jonathan W; Pant, Deepak; Mak, Harriet; Smargon, Aaron A; Sander, Tynan C; Garcia, Esaul; Lee, Dominic P; Cleveland, Don W; Yeo, Gene W

Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders

基于可编程大分子RNA靶向疗法治疗人类神经系统疾病

Morelli, Kathryn H; Smargon, Aaron A; Yeo, Gene W

Crosstalk between CRISPR-Cas9 and the human transcriptome

CRISPR-Cas9 与人类转录组之间的串扰

Aaron A Smargon, Assael A Madrigal, Brian A Yee, Kevin D Dong, Jasmine R Mueller, Gene W Yeo

Engineered U1 snRNAs to modulate alternatively spliced exons

改造 U1 snRNA 来调节可变剪接的外显子

Samuel T Hatch, Aaron A Smargon, Gene W Yeo

RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering

从宏基因组发现到转录组工程:靶向RNA的CRISPR系统

Smargon, Aaron A; Shi, Yilan J; Yeo, Gene W

Diversity and evolution of class 2 CRISPR-Cas systems

第二类 CRISPR-Cas 系统的多样性和演化

Shmakov, Sergey; Smargon, Aaron; Scott, David; Cox, David; Pyzocha, Neena; Yan, Winston; Abudayyeh, Omar O; Gootenberg, Jonathan S; Makarova, Kira S; Wolf, Yuri I; Severinov, Konstantin; Zhang, Feng; Koonin, Eugene V